Related Experiment Videos
Summary
Epithelial cells, not fibroblasts, show inducible glucose-6-phosphatase (G-6-Pase) activity. This finding enables the diagnosis of Von Gierke
Area of Science:
- Biochemistry
- Cell Biology
- Medical Genetics
Background:
- Glucose-6-phosphatase (G-6-Pase) is a key enzyme in glucose metabolism.
- Von Gierke's disease is a metabolic disorder characterized by G-6-Pase deficiency.
- Accurate diagnosis of metabolic diseases is crucial for timely intervention.
Purpose of the Study:
- To investigate the presence and inducibility of G-6-Pase activity in different human cell types.
- To evaluate the utility of cultured epithelial cells for diagnosing Von Gierke's disease.
- To explore the potential for prenatal diagnosis of Von Gierke's disease using amniotic fluid-derived cells.
Main Methods:
- Culturing epithelial cells and fibroblasts from human liver and amniotic fluid.
- Assessing G-6-Pase activity in cultured cells.
- Inducing G-6-Pase activity using dibutyryl cyclic AMP and theophylline.
Main Results:
- Inducible G-6-Pase activity was found exclusively in epithelial cells, not fibroblasts.
- Diagnosis of Von Gierke's disease was achieved using cultured liver epithelial cells from a patient.
- Epithelial cells from the patient showed no inducible G-6-Pase activity.
- Amniotic fluid-derived epithelial cells demonstrated a 2- to 3-fold increase in G-6-Pase activity after stimulation.
Conclusions:
- Cultured epithelial cells are a viable tool for diagnosing metabolic diseases like Von Gierke's disease.
- This study represents the first use of epithelial cells for diagnosing a metabolic disorder.
- Prenatal diagnosis of Von Gierke's disease may be feasible using amniotic fluid-derived epithelial cells in specialized laboratories.